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A B S T R A C T
Anthelmintic resistant gastrointestinal helminths have become a major cause of poor health in sheep and goats.
Sensitive and specific molecular markers are needed to monitor the genotypic frequency of resistance in field
parasite populations. Gastrointestinal nematode resistance to benzimidazole is caused by a mutation in one of
three positions within the isotype 1 β-tubulin gene. In the absence of markers for resistance to the other broad
spectrum anthelmintic classes, these provide a relevant study example. Determination of the prevalence of these
single nucleotide polymorphisms in field nematode populations can be impractical using conventional molecular
methods to examine individual parasites; which can be laborious and lack sensitivity in determining low levels of
resistance in parasite populations. Here, we report the development of a novel method based on an Illumina
MiSeq deep amplicon sequencing platform to sequence the isotype 1 β-tubulin locus of the small ruminant
gastrointestinal nematode, Teladorsagia circumcincta, and determine the frequency of the benzimidazole re-
sistance mutations. We validated the method by assessing sequence representation bias, comparing the results of
Illumina MiSeq and pyrosequencing, and applying the method to populations containing known proportions of
resistant and susceptible larvae. We applied the method to field samples collected from ewes and lambs on over a
period of one year on three farms, each highlighting different aspects of sheep management and approaches to
parasite control. The results show opportunities to build hypotheses with reference to selection pressures leading
to differences in resistance allele frequencies between sampling dates, farms and ewes or lambs, and to consider
the impact of their genetic fixation or otherwise. This study provides proof of concept of a practical, accurate,
sensitive and scalable method to determine frequency of anthelmintic resistance mutations in gastrointestinal
nematodes in field studies and as a management tool for livestock farmers.
1. Introduction
Resistance to broad spectrum anthelmintic drugs is a global threat
to efficient livestock production (Kaplan, 2004; Kaplan and
Vidyashankar, 2012). Anthelmintic drugs belonging to the tubulin
binding benzimidazole class are the mainstay for the control gastro-
intestinal nematode in lower and middle income countries (Ali et al.,
2019; Chaudhry et al., 2015). The benzimidazole drugs are also routi-
nely used in intensive small ruminant production throughout Europe,
despite the widespread emergence and gene flow of resistance to the
drug group in most small ruminant production limiting gastrointestinal
nematode species (Borgsteede et al., 1991; Fleming et al., 2006). A
large-scale survey of UK sheep farms showed the benzimidazole re-
sistance phenotype in 64–77% of farms, almost exclusively in the pre-
dominant gastrointestinal nematode species, Teladorsagia circumcincta
(Bartley et al., 2003; Mitchell et al., 2010). Benzimidazole resistance is
an emerging problem around the world in regions where efficient small
ruminant production is essential in poverty alleviation (Lalljee et al.,
2018) and where alternative anthelmintic drug groups are hitherto
unavailable or prohibitively expensive (Sargison et al., 2017; Van Wyk
et al., 1989; Wong and Sargison, 2018).
Benzimidazole resistance is associated with mutations in the isotype
1 β-tubulin gene that prevent drug binding (Geary et al., 1992a). A
single nucleotide polymorphism (SNP) mutation was first identified in
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benzimidazole resistant Haemonchus contortus and Trichostrongylus co-
lubriformis resulting in an amino acid substitution from tyrosine to
phenylalanine at position 200 (F200Y) of the polypeptide encoded by
the isotype 1 β-tubulin gene (Kwa et al., 1994, 1995). The same point
mutation was also shown in benzimidazole resistant T. circumcincta
(Elard et al., 1996). This F200Y SNP is considered to be the most im-
portant mutation conferring benzimidazole resistance, and has been
shown to be functionally significant with respect to the benzimidazole
resistance phenotype by transfection of the gene into Caenorhabditis
elegans (Kwa et al., 1995). A substitution from tyrosine to phenylalanine
at position 167 (F167Y) of the polypeptide encoded by the isotype 1 β-
tubulin gene has been found in T. circumcincta and H. contortus
(Silvestre and Cabaret, 2002). A third isotype 1 β-tubulin mutation
(E198A) with substitution from glutamate to alanine at position 198
was first identified in field populations of H. contortus (Chaudhry et al.,
2015; Ghisi et al., 2007; Rufener et al., 2009) and has subsequently
been reported in T. circumcincta with two substitutions (E198L [TTA] or
E198A [GCA]) (Redman et al., 2015).
The emergence and spread of benzimidazole resistance in parasite
populations is aided by high effective population sizes and high mu-
tation rates (Redman et al., 2015). Selection for anthelmintic resistance
is influenced by the timing and frequency of treatments with reference
to the proportion of the total gastrointestinal nematode population that
is exposed to the drug, or in a refuge from exposure, referred to as in
refugia (van Wyk, 2001). Pragmatic advice on reducing the selection
pressure for anthelmintic resistance is generally based around avoid-
ance of selection of pre-existing resistant nematodes by not affording
them a competitive advantage over susceptible nematodes. Another
major influence is the movement of animals infected with drug resistant
parasites, leading to gene flow (Kaplan and Vidyashankar, 2012;
Redman et al., 2015; Skuce et al., 2010a). Anthelmintic resistance se-
lection and gene flow pressures vary within, and between, seasons and
with changing management; hence in the absence of conclusive evi-
dence in support of any single risk factor, the most pragmatic advice
given is to instigate mitigation strategies in response to monitoring the
resistance status of individual flocks or herds (Ali and Hennessy, 1996).
In vivo methods for the diagnosis of benzimidazole resistance, such
as the faecal egg count reduction test (FECRT), confirm anthelmintic
efficacy by comparing the number of eggs shed in host faeces before
and after treatment (Coles et al., 1992, 2006). However, the FECRT for
benzimidazole efficacy requires a lag of 10–14 days between each
measurement and has poor sensitivity, in particular when less than 25%
of the parasite population is resistant (Martin et al., 1989). In vitro
bioassays, such as the egg hatch test (EHT), expose parasites to titrated
concentrations of thiabendazole and measure the number of first stage
larvae that hatch. However, the EHT depends on extraction of freshly
voided eggs and also has poor sensitivity at low levels of resistance
(Taylor et al., 2002).
Various molecular assays and platforms, including conventional
PCR (Kwa et al., 1994), combined use of PCR with a restriction enzyme,
allele specific PCR (Elard et al., 1996), cloning and Sanger sequencing
analysis (Ghisi et al., 2007), real-time PCR (Alvarez-Sanchez et al.,
2005), single strand conformation polymorphism (SSCP) genotyping
(Skuce et al., 2010b), and pyrosequence genotyping (Samson-
Himmelstjerna, 2006), have been used to identify the isotype 1 β-tu-
bulin SNPs in gastrointestinal nematodes. Of these, only real-time PCR
and pyrosequencing can provide a practical estimate of allele frequency
from pooled samples in a practical way required for large scale field
studies, or routine monitoring.
Pyrosequencing is restricted to short fragments of up to 30 bp, while
deep amplicon sequencing using Illumina MiSeq can accurately se-
quence up to about 400 bp reads when used to study nematode species
compositions of mixed populations (Avramenko et al., 2015). The
method might, therefore, be more sensitive in detecting low frequencies
of resistance mutations than conventional methods; while allowing
investigation of all three SNPs involved in benzimidazole resistance at
once. Of the available next generation sequencing platforms, Illumina
MiSeq is least error prone, and best suited to high throughput (Ali et al.,
2019; Avramenko et al., 2019). Moreover, Avramenko et al. (2019)
undertook a detailed validation study of deep amplicon sequencing to
identify the three resistance associated SNPs in the isotype-1 β-tubulin
in six different ovine trichostrongylid nematode species.
In the present study, we report the use of deep amplicon sequencing
using Illumina MiSeq for the detection of benzimidazole resistance in T.
circumcincta. A series of experiments was performed to develop and
validate the Illumina MiSeq method for measuring resistance allele
frequency. First, the number of PCR cycles to amplify DNA before se-
quencing was varied to identify any sequence representation bias.
Second, the results from Illumina MiSeq of T. circumcincta laboratory
populations were compared to those from pyrosequencing assays.
Third, pools were made from resistance allele-genotyped individual
third stage larvae (L3) gDNA to validate the Illumina MiSeq assay.
Finally, the assay was applied to T. circumcincta field populations to
identify the frequencies of benzimidazole resistance mutations.
2. Materials and methods
2.1. Parasite materials
Six experimentally passaged and stored T. circumcincta laboratory
populations were obtained from the Moredun Research Institute,
named 1-S (benzimidazole susceptible), 2-R (benzimidazole resistant),
3-R, 4-S, 5-R, 6-R. Pools of larvae (~200 L3) were created, by taking
50 μl aliquots from corresponding dilutions in distilled water of each of
the six laboratory populations. Three replicate pools of each T. cir-
cumcincta laboratory population were used with 25, 30, 35, or 40 first
round Illumina MiSeq PCR cycles to assess accuracy and determine any
sequence representation bias. Three replicate pools of each T. cir-
cumcincta laboratory population were used for the comparison of the
Illumina MiSeq with the pyrosequencing assays.
To quantitatively validate the identification of benzimidazole sus-
ceptible or resistant L3, 48 individual 1-S L3 and 48 individual 5-R L3
were first picked into distilled water. Lysates were then prepared for
pyrosequence genotyping of the isotype 1 β-tubulin codon 200 locus.
1 μl of lysate from known genotyped individual L3 was used to create
three replicates each of five admixtures of homozygous susceptible (S:
TTC) and homozygous resistant (R: TAC) L3 gDNA.
T. circumcincta field populations were derived from ewes and lambs
on three neighbouring farms in the south-east of Scotland over multiple
time points during 2016 and 2017. Farm 1 was a lowland farm with an
open sheep flock of about 370 crossbred ewes; Farm 2 was a lowland
farm with an open sheep flock of about 680 crossbred ewes; Farm 3 was
an extensive hill farm with a closed sheep flock of about 700 hefted
Scottish Blackface ewes. There was no movement of animals, or shared
grazing between Farm 1 and Farms 2 or 3, but occasional straying
between Farms 2 and 3 would have been possible. The faecal samples
were collected per rectum, or freshly voided onto the pasture.
Following faecal trichostrongyle nematode egg counting using a salt
flotation method with a potential sensitivity of one egg per gram
(Christie and Jackson, 1982), coprocultures were set up for the recovery
of L3 (Coles et al., 1992). Pools of about 700 L3 were created, by taking
500 μl aliquots from corresponding dilutions in distilled water for each
field sample. Ethical approval was acquired through Veterinary Ethics
Review Committee (VERC) at the University of Edinburgh, reference
number VERC 10 16 and consent was given by the farms’ managers.
2.2. Genomic DNA extraction
gDNA was prepared using 1000 μl Direct PCR lysis reagent (Viagen),
50 μl proteinase K solution (Qiagen), and 50 μl 1M dithiothreitol (DTT).
To extract gDNA, 25 μl of the mixture was added to each well of a 96-
well plate prior to addition of the L3. The plate was placed on a
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thermocycler to incubate at 60 °C for 2 h to lyse the larvae followed by
85 °C for 15min to inactivate the proteinase K. For pooled L3, the
samples were first centrifuged for 2min at 7200×g. The supernatant
was discarded, and the pellet re-suspended in 50 μl of lysis buffer,
which was then placed on a thermocycler with the same conditions
described for individual larvae preparation. Genomic DNA was stored
at −80 °C for later use.
2.3. Illumina MiSeq deep amplicon sequencing of the T. circumcincta
isotype 1 β-tubulin locus
Illumina MiSeq was used to sequence a 276 bp fragment of isotype 1
β-tubulin spanning the F200Y, F167Y, and E198L or E198A SNPs. In the
first round PCR, a 276 bp fragment of isotype 1 β-tubulin of T. cir-
cumcincta was amplified with four forward and four reverse adaptor
primers (Supplementary Table S1A). The PCR reaction contained 0.5 μl
of KAPA HiFi polymerase (KAPA Biosystems), 0.75 μl dNTPs (10 μM),
5 μl 5X KAPA HiFi Fidelity buffer (KAPA Biosystems), 0.75 μl of each for
forward and reverse primer mix (10mM), 13.25 μl nuclease-free water,
and 1 μl template DNA. The thermocycling conditions were 95 °C for
2min, 35 cycles of 98 °C for 20 s, 60 °C for 15 s, 72 °C for 15 s, then a
final extension of 72 °C for 2min and hold at 10 °C. PCR products were
purified with AMPure XP Magnetic Beads (1×) (Beckman coulter, Inc.)
using a special magnetic stand (DynaMag) in accordance with the
protocols described by Beckman coulter, Inc.
The second round PCR was performed by using 16 forward and 24
reverse barcoded primers. (Supplementary Table S1B). Each sample
was amplified using a unique combination of barcode primers. The PCR
reaction contained 0.5 μl of KAPA HiFi polymerase (KAPA Biosystems),
0.75 μl dNTPs (10mM), 5 μl 5X KAPA HiFi Fidelity buffer (KAPA Bio-
systems), 1.25 μl of each primer (10 μM), 13.25 μl nuclease-free water
and 2 μl of the first round PCR product as a template. The thermo-
cycling conditions of the PCR were 98 °C for 45 s, followed by 7 cycles
of 98 °C for 20 s, 63 °C for 20 s, and 72 °C for 2min. PCR products were
purified with AMPure XP Magnetic Beads (1×) according to the pro-
tocols described by Beckman coulter, Inc.
The pooled library was measured with KAPA qPCR library quanti-
fication kit (KAPA Biosystems, USA). The prepared library was then run
on an Illumina MiSeq sequencer using a 500-cycle pair end reagent kit
(MiSeq Reagent Kits v2, MS-103-2003) at a concentration of 15 nM
with addition of 10–15% Phix Control v3 (Illumina, FC-11-2003).
2.4. Illumina MiSeq data handling
Reference sequence libraries were generated by aligning the T. cir-
cumcincta isotype 1 β-tubulin sequences downloaded from the NCBI
database (Supplementary Table S2) using Geneious v10.2.5 software
(Biomatters Ltd, New Zealand). Overall seventy three reference se-
quences were chosen to represent the spectrum of sequence diversity of
T. circumcincta isotype 1 β-tubulin locus. Illumina MiSeq separated all
sequence data by population during post-run processing by recognised
indices and to generate FASTQ files use in subsequent analysis. MiSeq
data analysis was performed with a bespoke pipeline (for (more details
Supplementary Data S1) using Mothur v1.39.5 software (Schloss et al.,
2009) and the Illumina MiSeq SOP (Kozich et al., 2013). Briefly, raw
paired-ends reads were run into the make.contigs command to combine
the two set of reads for each population. The command was to extract
the sequence and quality score data of FASTQ files, create the com-
plement of the reverse and forward reads, and then join the reads into
contigs. Sequence data were removed if they were>500 bp or if the
reads were too long, or contained ambiguous bases. The sequence data
were then aligned with the T. circumcincta reference sequence library
(Supplementary Table S2) using the align.seqs command and were re-
moved if they did not match with the T. circumcincta isotype 1 β-tubulin
locus. The summary.seqs command was used to summarise the 277 bp
fragments encompassing parts of the T. circumcincta isotype 1 β-tubulin.
All of the bulk sequence overlap region was further run on the
screen.seqs command to generate the T. circumcincta isotype 1 β-tubulin
sequences FASTQ file. Once all bulk sequences were classified as T.
circumcincta, a count list of the consensus sequences of each population
was created using the unique.seqs command. The count list was further
used to create the FASTQ files of the consensus sequences of each po-
pulation using the split.groups command (for more details Supple-
mentary Data S1).
2.5. Phylogenetic analysis of the T. circumcincta isotype 1 β-tubulin locus
with other trichostrongylid nematode species of small ruminants
The consensus sequences of T. circumcincta isotype 1 β-tubulin were
aligned using the MUSCLE alignment tool in Geneious v10.2.5 software
(Biomatters Ltd, New Zealand). Details of the sequence data are pre-
sented in Supplementary Data S2 and S5. Reference sequence libraries
of seven other gastrointestinal nematode species (Cooperia curticei,
Trichostrongylus axei, Trichostrongylus vitrinus, Trichostrongylus colu-
briformis, Haemonchus placei, Haemonchus contortus and Nematodirus
battus) were created from a previously published data set (Ali et al.,
2019; Avramenko et al., 2019; Chaudhry et al., 2015; Chaudhry et al.,
2015). The obtained isotype 1 β-tubulin sequences of seven species
were first aligned in Geneious v10.2.5 (Biomatters Ltd, New Zealand). A
phylogenetic tree was constructed by the Kimura 2-parameter model of
substitution using the Maximum Likelihood method in the MEGA 5.05
software. The program jModeltest 12.2.0 was used to select the ap-
propriate model of nucleotide substitutions for phylogenetic analysis.
Branch supports were obtained by 1000 bootstraps of the data. The
sequences of the isotype 1 β-tubulin locus demonstrated separate
clustering of T. circumcincta in the phylogenetic tree, indicating correct
taxonomic assignment of species (Supplementary Fig. S1).
2.6. Statistical analysis
The frequency of benzimidazole resistance mutations (F200Y (TAC),
F167Y and E198L) was calculated by dividing the number of sequences
reads of each population that contained the mutation by the total
number of reads. The effect of PCR cycle number on resistance fre-
quency was analysed by running a Kruskal-Wallis rank sum test for each
population. Statistical significance in this test would imply a sequence
representation bias. A chi-square test was used to determine whether
there was a significant difference between allele frequencies of benzi-
midazole resistant and susceptible individual T. circumcincta L3 and for
the comparison of the Illumina MiSeq deep amplicon sequencing with
the pyrosequencing assay. Lin's Concordance Correlation Coefficient
was calculated by assessing the agreement level between lamb and ewe
samples collected from the three field study farms (DescTools: Tools for
Descriptive Statistics).
2.7. Pyrosequence genotyping of the T. circumcincta isotype 1 β-tubulin
locus
A 276bp fragment of isotype-1 β-tubulin spanning F200Y, F167Y,
and E198L or E198A was amplified with the BTUB_FOR and biotin la-
belled BTUB_REV primers previously described by Silvestre and
Humbert (2002) and Skuce et al. (2010a) (Supplementary Table S1A).
The PCR reaction contained 0.5 μl of 5 U/μl Taq polymerase (New
England Biolabs), 0.5 μl dNTPs (10mM), 5 μl 10X standard buffer (New
England Biolabs), 0.5 μl of each primer (10 μM), 42 μl nuclease-free
water and 1 μl DNA template. The thermocycling parameters were 95 °C
for 5min, 35 cycles of 95 °C for 1min, 60 °C for 1min, and 72 °C for
1min, then a final extension at 72 °C for 15min and hold at 10 °C.
Following PCR amplification, the relative frequency of the F200Y,
F167Y, and E198L or E198A SNPs were determined by separate pyr-
osequencing assays using the PyroMark ID system using the allele
quantification (AQ) mode of the PSQ 96 single nucleotide position
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software (Biotage, Sweden). Pyrosequencing primers have been suc-
cessfully used to genotype the T. circumcincta isotype 1 β-tubulin locus
from individual larvae using SNP mode (Skuce et al., 2010a). In our
hands there are some technical limitation to use this method on pooled
samples, therefore, new pyrosequencing primers were designed to
target each mutation in six populations (Supplementary Table S1).
PyroMark Q96 ID reagents (Qiagen) were used according to the user
manual. The base dispensation was set to GTAGCTGTC for codon 200,
GTAGCTCA for codon 167, and GATATCGA for codon 198. Peak
heights of samples with an unknown number of larvae or individual
larvae were measured either in AQ or SNP mode of the PSQ 96 single
nucleotide position software previously described by Chaudhry et al.
(2015).
3. Results
3.1. The effect of first round PCR cycle number on the frequency of the
isotype 1 β-tubulin locus SNPs in larval pools
To assess accuracy and determine any sequence representation bias,
three replicates of each mock pool were amplified from the six T. cir-
cumcincta laboratory populations using four different numbers of first
round PCR cycles. According to a Kruskal-Wallis rank sum test (per-
formed separately for each of the mock populations), differences in the
proportion of resistant or susceptible alleles at each SNP with the
number of PCR cycles were not statistically significant (overall
H(3) < 0.2, p>0.9). Therefore, no sequence representation bias was
observed in the estimation of benzimidazole resistance allele fre-
quencies of the laboratory populations. The F200Y (TAC) SNP was
found at different frequencies of between 67.2% and 94.5% in the four
phenotypically benzimidazole resistant (2-R, 3-R, 5-R and 6-R) popu-
lations and consistently between 3% and 11.6% in the two phenoty-
pically benzimidazole susceptible (1-S and 4-S) populations (Fig. 1 and
Supplementary Table S3). The benzimidazole resistance-associated
F167Y (TAC) SNP was identified at a frequency of between 2% and
4.3% in the 6-R population (Fig. 1 and Supplementary Table S3). The
benzimidazole resistance associated E198L (TTA) and E198A (GCA)
SNPs were not detected in any of the populations. Subsequent work
used 30 cycles for the first round PCR.
3.2. Comparison of the Illumina MiSeq deep amplicon sequencing and
pyrosequencing assays to determine the frequency of benzimidazole
resistance SNPs
For the comparison of the Illumina MiSeq with the pyrosequencing
assay, three replicates each mock pool were taken from six T. cir-
cumcincta laboratory population. While there were variations between
the results of the two methods (with the Illumina MiSeq method ap-
parently more sensitive at low SNP frequencies), differences in the
frequency of the benzimidazole resistance SNPs determined by Illumina
MiSeq and pyrosequencing were not statistically significant (Chi-square
test: χ2(4) = 3.962, p=0.4112). The F200Y (TAC) SNP was found at
different frequencies in the different populations of between 11.3% and
94.5% in the Illumina MiSeq and 8.2% and 85.3% in the pyrosequen-
cing assay (Fig. 2 and Supplementary Table S4). The F200Y (TAC) and
F167Y (TAC) SNPs were only detected at low frequencies of 3.7% and
4.5% by Illumina MiSeq in the 4-S and 6-R populations, respectively,
but were not identified by the pyrosequencing assay (Fig. 2 and
Supplementary Table S4). The benzimidazole resistance associated
E198L (TTA) and E198A (GCA) SNPs were not detected by either
method in any of the populations.
3.3. Validation of the proportions of benzimidazole resistant and susceptible
individual T. circumcincta L3
To assess the accuracy of the Illumina MiSeq platform in identifying
the frequencies of benzimidazole susceptible 1-S and resistant 5-R in-
dividual L3 were first genotyped by pyrosequencing for the F200Y
mutation. This identified homozygous susceptible (S: TTC) and homo-
zygous resistant (R: TAC) alleles. Three replicates each of known ad-
mixtures were created of individual L3 gDNA from populations that had
been pyrosequence genotyped, allowing gDNA pools to be produced
with known allele frequencies at the isotype 1 β-tubulin codon 200
locus and used to validate the Illumina MiSeq method. There was no
statistically significant difference between the expected and observed
frequencies of susceptible and resistance alleles in a chi-square test,
which suggests that the Illumina MiSeq method was accurate in mea-
suring resistance allele frequencies (Chi-square test; mixS: χ2(1) < 0.001,
p=1; mixR: exact match; mixSR: χ2(1)< 0.001, p=1; mixSRR:
χ2(1)= 0.057, p=0.845; mixSSR: χ2(1) = 0.065, p=0.799) (Fig. 3,
Supplementary Table S5). For the pools of 100% susceptible or re-
sistance alleles (MixS(F200Y-TTC)-100, MixR (F200Y-TAC)-100], the
expected and observed results were perfectly matched (Fig. 3). For
pools of susceptible and resistance alleles [MixSR (F200Y-TTC/TAC)-,
MixSRR (F200Y-TTC/TAC)-MixSSR(F200Y-TTC/TAC)-], the expected
allele frequencies were 50/50, 33/67, 67/33 and observed results were
nearly accurate (68/32, 22/78, 77/23), with not-significant variations
between replicates (Fig. 3 and Supplementary Table S5).
3.4. Detection of isotype 1 β-tubulin locus SNPs in T. circumcincta field
populations using the Illumina MiSeq deep amplicon sequencing method
The Illumina MiSeq deep amplicon sequencing was used to detect
the frequency of isotype 1 β-tubulin locus SNPs in field samples, In
total, field samples from 48 ewes and 37 lambs from three farms were
collected at multiple time points in 2016 and 2017. Those samples
yielding fewer than 2000 reads (implying insufficient gDNA for accu-
rate amplification) were removed from the analysis, leaving 43 ewe and
31 lamb samples (Supplementary Table S6). The allele frequencies of
benzimidazole resistance mutations are shown in Fig. 4. For Farm 1, the
F200Y resistance allele frequency was between 78% and 100% in both
ewes and lambs. For Farm 2, the F200Y resistance allele frequency was
between 61.7% and 80.2% in the lambs, but varied between 10% and
92% in the ewes. For Farm 3, the F200Y resistance allele frequency was
between 64.6% and 90.2% in the lambs, but varied between 25.3% and
88.5% in the ewes. The F167Y allele frequency was between 0.5% and
6.6% on all three farms. The E198L (TTA) allele frequency was between
0.1% and 13.9% on all three farms (Fig. 4A). In terms of overall pre-
valence, the F200Y (TAC) resistance-associated SNP was found on all
three farms in each of the ewe and lamb samples collected at different
time-points. The F167Y (TAC) resistance associated SNP was detected
in 9/12 ewe and 7/13 lamb time-point samples on Farm 1; in 7/20 ewe
and 7/9 lamb time-point samples on Farm 2; and in 2/11 ewe and 5/9
lamb time-point samples on Farm 3. The E198L (TTA) resistance as-
sociated SNP was detected in 12/12 ewe and 11/13 lamb time-point
samples on Farm 1; 15/20 ewe and 9/9 lamb time-point samples on
Farm 2; and 5/11 ewe and 8/9 lamb time-point samples on Farm 3
(Fig. 4B). Overall, the statistical correlation [(rc= 0.983
(0.791–0.946)] shows a high level of agreement between lamb and ewe
samples from each of the three farms (Fig. 4C).
4. Discussion
Genotypic markers for anthelmintic resistance and sensitive and
accurate platforms with which to measure them are needed for accurate
surveillance to assess, and mitigate, the impacts of climate change,
animal husbandry practices and pasture management on the emergence
and spread of anthelmintic resistance mutations. In vivo bioassays such
as the egg hatch and larval development (Coles et al., 1992) tests for
benzimidazole resistance may be influenced by extrinsic or separate
genetic factors governing traits such as fitness in the test environment,
or by variation in the test conditions. Furthermore, the mechanisms of
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drug resistance in eggs and developing larvae may differ from those in
parasitic stages (Kotze et al., 2012). The in vivo faecal egg count re-
duction test is influenced by independent host factors, such as those
affecting drug bioavailability (Ali and Hennessy, 1996), or by the ac-
curacy or drug administration. Phenotypic assays are also influenced by
the number of genes involved and by the dominance or recessiveness of
the trait; hence are poor in the estimation of the frequency of resistance
alleles, in particular when the frequency is low. Hence, they may not
accurately reflect the emergence and spread of anthelmintic resistance
mutations in field populations of gastrointestinal nematodes at early
stages of development.
Validated genotypic markers for anthelmintic resistance are only
currently available for the benzimidazoles (Geary et al., 1992b), albeit
marker discovery is a research priority for the imidazothiazole, mac-
rocyclic lactone and amino-acetonitrile derivative broad spectrum an-
thelmintic drug groups (Doyle et al., 2019). In this study, we used the
isotype 1 β-tubulin SNPs to develop a proof of concept method to ex-
amine the frequency of alleles in gastrointestinal nematode popula-
tions, with reference to better understanding of the impact of en-
vironmental factors on the emergence and spread of anthelmintic
resistance. Deep amplicon sequencing by Illumina MiSeq offers poten-
tial for greater practicality that is required for field investigations than
pyrosequencing, because: fewer replicates are needed to overcome the
chance of quality control failure; and separate pyrosequencing runs are
required for analysis of each isotype 1 β-tubulin SNP, spanning codons
167, 198 and 200, whereas the Illumina MiSeq platform allows for the
determination of multi-allelic polymorphisms spanning an approxi-
mately 400 bp locus. Illumina MiSeq involves two short PCRs and two
rounds of product purification before sequencing, and in our hands
provided informative read depths in at least 384 samples (four 96-well
plates) in a single library; hence is most practical for use in high
throughput scenarios (Avramenko et al., 2019). In this assay, amplicons
were generated from T. circumcincta laboratory and field L3 populations
and sequenced in depth using the Illumina MiSeq platform. The re-
sultant sequences were then bioinformatically assigned to the corre-
sponding parasite species on the basis of sequence identity when
compared against T. circumcincta isotype 1 β-tubulin consensus se-
quence taxonomy library. The allele frequencies of the three isotype 1
β-tubulin F200Y (TAC), F167Y and E198L SNPs for the T. circumcincta
populations were analysised using a bioinformatic pipeline described in
material and methods section 2.4. Briefly, raw paired-ends reads were
run into the make.contigs command, to remove the ambigious bases.
The sequence data were aligned with the T. circumcincta isotype 1 β-
tubulin consensus sequence library using the align.seqs command and
the un-aligned sequences were discarded. All the bulk sequence of 276
bp fragments overlaps the same region were run on the screen.seqs
command to generate the isotype 1 β-tubulin matched sequences of T.
circumcincta. Finally, the analysis of the three isotype 1 β-tubulin F200Y
(TAC), F167Y and E198L SNPs for the T. circumcincta populations was
performed using Geneious v10.2.5 software. Based on these commands,
we are confident that only T. circumcincta DNA was amplified. Fur-
thermore the field samples showed the predominance of T. circumcincta
in faecal samples from grazing ewes and lambs in each farm (data on
file). The other gastrointestinal nematode species identified on the
three farms were Oesophagostomum venulosum, Cooperia curticei, Tri-
chostrongylus axei, Trichostrongylus vitrinus and Trichostrongylus un-
classified (data on file).
We validated the Illumina MiSeq method to examine benzimidazole
Fig. 1. Average frequency of isotype 1 β-tubulin locus SNPs using four different PCR cycles for six T. circumcincta laboratory populations. This data was generated
from pooled samples with about 200 L3. The F200Y (TAC) resistance alleles were identified in all six populations with different frequencies. The F167Y (TAC) was
found only in the 6-R population (Supplementary Table S3). Dark grey shade indicates F167Y (TAC), medium grey indicates F200Y (TAC) and white indicates
susceptible alleles. X-axis represents the four PCR cycles numbers (25X, 30X, 35X, 40X) and Y-axis represents the allele frequencies. Error bars represent the standard
error of the mean.
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resistance allele frequencies in mock population pools of T. circumcincta
by: assessing sequence representation bias in the isotype 1 β-tubulin
locus; comparing the results of Illumina MiSeq and pyrosequencing; and
applying the method to populations containing known proportions of
resistant and susceptible L3. We identified no significant variation in the
frequency of resistance alleles with the number of first round PCR
cycles in any of the six reference T. circumcincta populations; hence
showed no sequence representation bias (Avramenko et al., 2015)
arising from the number of first round PCR cycles, or from potential
variation in the efficiency of other library preparation steps, or from
any inaccuracy in the estimation of the number of about 200 L3 making
up each mock population pool. The Illumina MiSeq method showed a
Fig. 2. Average frequency of isotype 1 β-tubulin locus SNPs in six T. circumcincta laboratory populations, determined by Illumina MiSeq and pyrosequencing. This
data was taken from pooled samples with about 200 L3. Dark grey shading indicates the F167Y (TAC) SNP, medium grey shading indicates the F200Y (TAC) SNP and
white indicates susceptible alleles. Error bars represent the standard error of the mean.
Fig. 3. Average frequency of the isotype 1
β-tubulin locus F200Y (TAC) SNP in mock
pools was made from different mixing of
pyrosequence genotyped 1-S individual
homozygous susceptible and 5-R homo-
zygous resistant T. circumcincta L3. The
symbol mix represents the mixing of re-
sistant-R and susceptible-S alleles. In the X-
axis, E represents the expected allele fre-
quencies and O represents the observed al-
lele frequencies based on Illumina MiSeq.
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higher F200Y (TAC) resistance allele frequency than pyrosequencing in
each of the six reference T. circumcincta populations, but the differences
were not shown to be statistically significant. This might imply that the
Illumina MiSeq method is more sensitive than pyrosequencing, but true
determination of sensitivity would require the genotyping the in-
dividual L3 making up each of the mock population pools as described
by (Avramenko et al., 2019). Five mock population pools containing
different estimated proportions of homozygous F200Y (TAC) resistance
mutations were generated by mixing fixed amounts of pyrosequence
genotyped individual L3 gDNA, derived from susceptible and drug se-
lected resistant laboratory T. circumcincta populations. For the pools
that were 100% resistant or 100% susceptible, the observed allele fre-
quencies based on Illumina MiSeq were in perfect agreement with ex-
pected allele frequencies. For pools with 67%, 50%, and 33% resistance
alleles, differences between the expected and observed frequencies of
the F200Y (TAC) mutation were not statistically significant (p > 0.9),
with little variation between replicates, providing support for the ac-
curacy of the Illumina MiSeq method in determining the frequency of
resistance alleles in a gastrointestinal nematode parasite population.
The small amount of variation between observed and expected allele
frequencies could have arisen in the creation of the mock pools using
only 1 μl of low concentration gDNA derived from about 90 individual
L3.
Gastrointestinal nematodes impact heavily on animal welfare and
production, hence there is a need to understand the population genetics
of anthelmintic resistance (Gilleard and Beech, 2007). Having validated
the Illumina MiSeq platform using mock pools of laboratory T. cir-
cumcincta isolates, we applied the method to field samples collected
from ewes and lambs on three farms, each highlighting different aspects
of sheep management and approaches to parasite control. This was
undertaken as proof of concept to explore the possibilities for the ap-
plication of a high throughput practical method to determine the pro-
portions of resistance alleles in particular gastrointestinal nematode
parasite species within mixed species field populations.
We have further examined the frequency of the total of the F200Y
(TAC), E198L (TTC) and F167Y (TAC) mutations with reference to re-
sistance allele frequencies in the field T. circumcincta populations. A
different pattern of resistance allele frequency over time emerged on
Farm 1 compared with Farm 2 and Farm 3. On farm 1, the overall
frequencies of resistance alleles in ewes and lambs were about 94% and
90%, respectively, whereas the overall frequencies of resistance alleles
in ewes and lambs on Farm 2/Farm 3 were 58%/70% and 77%/79%,
Fig. 4. Allele frequencies of isotype 1 β-tubulin locus SNPs in field populations of T. circumcincta. Red colour indicates F167Y (TAC), green indicates E198L (TTA) and
blue indicates F200Y (TAC) and purple indicates susceptible alleles. Fig. 4A: dots represent the resistance allele frequencies for each sampling time-point. The data
shows the three farms with date of sample collection on the X-axis and the Y-axis representing the allele frequencies. Fig. 4B: the pie charts show the overall
prevalence of the isotype 1 β-tubulin locus SNPs in ewes and lambs on each farm. The prevalence of SNPs and combinations of SNPs at farm level are shown in the
table below the figure. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
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respectively. Together these results indicate high frequencies of benzi-
midazole resistance alleles on all three farms, having nearly reached
genetic fixation on Farm 1. This scenario highlights an opportunity to
use the results of high throughput anthelmintic resistance allele geno-
typing to investigate the genetic selection pressures and question
management practices that might have impacted on them. For example,
there had been little uptake of mitigation strategies on Farm 1 following
the first diagnosis of anthelmintic resistance in 2000 (data on file);
whereas Farm 2 had ceased anthelmintic treatments of periparturient
ewes and implemented alternative grazing management with cattle
following the diagnosis of anthelmintic resistance in 2001 (Sargison
et al., 2001); and Farm 3 had cautiously reduced the anthelmintic
treatment frequency of ewes and lambs and adopted refugia manage-
ment strategies involving delayed treatments of lambs moved onto safe
in-bye pastures, and avoidance of whole group treatments following the
diagnosis of anthelmintic resistance in 2005 (Sargison et al., 2005). It is
intriguing to consider the genetic fixation of benzimidazole resistance
alleles on Farm 1 in the context of the sheep flock being open, having
introduced replacement ewes annually that presumably (based on our
observations in farm 2 and 3) harboured benzimidazole susceptible
genotypes. The gene flow of alleles conferring susceptibility to benzi-
midazole drugs on Farm 1 may have been halted by strategic treatments
of the introduced animals with amino-acetonitrile derivative, or an-
thelmintic drug combinations. This failure to introduce susceptible
genotypes might challenge the application of dogma surrounding
quarantine treatments of introduced animals with anthelmintic drug
combinations (Leathwick and Besier, 2014). However, quarantine
treatments are needed to mitigate the impact of resistance to each of the
broad spectrum anthelmintic drug classes at once, hence the strategy of
allowing the introduction of susceptible genotypes would only be ap-
propriate if the population genetics of resistance alleles for each group
were to be understood at an individual farm level (Greer et al., 2009).
This would require molecular markers for resistance to each of the
anthelmintic drug groups. Once genetic fixation of resistance alleles has
occurred, the probabilities of success of key mitigation strategies, such
as the use of anthelmintic drug combinations (Leathwick et al., 2015),
or refugia management involving targeted selective treatments (Greer
et al., 2009), in achieving reversion to drug susceptibility are reduced.
On Farm 2 and Farm 3, where genetic fixation had not been
reached, there were some between sample variations in the frequency
of benzimidazole resistance alleles. Some of this would have been due
to stochastic effects caused by different numbers of T. circumcincta L3 in
the sample pools, but the observation nevertheless highlights oppor-
tunities to map sustained trends in the frequency of resistance alleles,
indicating genetic drift or bottlenecks, to climatic variation and specific
practices, such as anthelmintic drug treatments and grazing manage-
ment. This was unrewarding in this case, where no benzimidazole
treatments were administered in Farm 2 and Farm 3, and possibly be-
cause the frequency of resistance alleles was already too high to detect
significant changes; showing a need for molecular surveillance starting
before resistance reaches a level where it can be phenotypically iden-
tified. The similarities that were observed in the resistance SNP fre-
quencies generated from parasite populations harvested from in-
dividual co-grazed animals suggest that it is possible to screen parasite
communities on pasture for resistance SNPs from a small number of
hosts.
In summary, there is a pressing need for high throughput methods
to determine the frequency of anthelmintic resistance conferring mu-
tations, or markers, in field populations of gastrointestinal nematodes.
We have demonstrated the feasibility and practicality of deep amplicon
sequencing by Illumina MiSeq in this regard, using benzimidazole re-
sistance in T. circumcincta as proof of concept, and have considered how
knowledge of resistance allele frequencies in field populations might be
used to build hypotheses on selection pressures and inform mitigation
strategies. The method has previously been applied to other gastro-
intestinal nematode species, and multiplexed to study benzimidazole
resistance co-infections (Avramenko et al., 2019). Once markers be-
come available, the method might also be used to study single or
multiple mutations conferring resistance to other anthelmintic drug
groups, and combined with phylogenetic tools to show their emergence
and spread.
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